Article
A combined analysis of 48 type 2 diabetes genetic risk variants shows no discriminative value to predict time to first prescription of a glucose lowering drug in Danish patients with screen detected type 2 diabetes.
PloS one - 1 Jan 2014
Hornbak Malene, Allin Kristine Højgaard, Jensen Majken Linnemann, Lau Cathrine Juel, Witte Daniel, Jørgensen Marit Eika, Sandbæk Annelli, Lauritzen Torsten, Andersson Åsa, Pedersen Oluf, Hansen Torben
Abstract excerpt
OBJECTIVE: To investigate the genetic influence of 48 type 2 diabetes susceptibility variants on disease progression measured as risk of early prescription redemption of glucose lowering drugs in screen-detected patients with type 2 diabetes. METHODS: We studied type 2 diabetes progression in 1,480 patients with screen-detected type 2 diabetes from the ADDITION-Denmark study using information of redeemed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.